181 related articles for article (PubMed ID: 35979621)
1. Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway.
Gao Q; Cheng B; Chen C; Lei C; Lin X; Nie D; Li J; Huang L; Li X; Wang K; Huang A; Tang N
Clin Transl Med; 2022 Aug; 12(8):e995. PubMed ID: 35979621
[TBL] [Abstract][Full Text] [Related]
2. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
3. UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
Guo B; Xu X; Shao M; Yang X; He G; Qi K; Gu J; Wang L
Biochem Biophys Res Commun; 2022 Jul; 613():207-213. PubMed ID: 35617808
[TBL] [Abstract][Full Text] [Related]
4. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis.
Wang X; Liu R; Zhu W; Chu H; Yu H; Wei P; Wu X; Zhu H; Gao H; Liang J; Li G; Yang W
Nature; 2019 Jul; 571(7763):127-131. PubMed ID: 31243371
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanism of Y473 phosphorylation of UGDH relieves the inhibition effect of UDP-glucose on HuR.
Liu Y; Li Y; Li G; Chu H
Phys Chem Chem Phys; 2023 Mar; 25(12):8714-8724. PubMed ID: 36896759
[TBL] [Abstract][Full Text] [Related]
6. GSTZ1-1 downregulates Wnt/β-catenin signalling in hepatocellular carcinoma cells.
Lei C; Wang Q; Tang N; Wang K
FEBS Open Bio; 2020 Jan; 10(1):6-17. PubMed ID: 31782257
[TBL] [Abstract][Full Text] [Related]
7. UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology.
Price MJ; Nguyen AD; Byemerwa JK; Flowers J; Baëta CD; Goodwin CR
Oncotarget; 2023 Sep; 14():843-857. PubMed ID: 37769033
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis.
Vigetti D; Ori M; Viola M; Genasetti A; Karousou E; Rizzi M; Pallotti F; Nardi I; Hascall VC; De Luca G; Passi A
J Biol Chem; 2006 Mar; 281(12):8254-63. PubMed ID: 16418163
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of UDP-glucose dehydrogenase affects glycosaminoglycans synthesis and motility in HCT-8 colorectal carcinoma cells.
Wang TP; Pan YR; Fu CY; Chang HY
Exp Cell Res; 2010 Oct; 316(17):2893-902. PubMed ID: 20691680
[TBL] [Abstract][Full Text] [Related]
10. Regulation of UDP-glucose dehydrogenase is sufficient to modulate hyaluronan production and release, control sulfated GAG synthesis, and promote chondrogenesis.
Clarkin CE; Allen S; Kuiper NJ; Wheeler BT; Wheeler-Jones CP; Pitsillides AA
J Cell Physiol; 2011 Mar; 226(3):749-61. PubMed ID: 20717929
[TBL] [Abstract][Full Text] [Related]
11. Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis.
Lin LH; Chou HC; Chang SJ; Liao EC; Tsai YT; Wei YS; Chen HY; Lin MW; Wang YS; Chien YA; Yu XR; Chan HL
J Cell Mol Med; 2020 Oct; 24(20):11883-11902. PubMed ID: 32893977
[TBL] [Abstract][Full Text] [Related]
12. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
13. UDP-glucose dehydrogenase: structure and function of a potential drug target.
Egger S; Chaikuad A; Kavanagh KL; Oppermann U; Nidetzky B
Biochem Soc Trans; 2010 Oct; 38(5):1378-85. PubMed ID: 20863317
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human UDP-glucose dehydrogenase expression using siRNA expression vector in breast cancer cells.
Huh JW; Choi MM; Yang SJ; Yoon SY; Choi SY; Cho SW
Biotechnol Lett; 2005 Aug; 27(16):1229-32. PubMed ID: 16158268
[TBL] [Abstract][Full Text] [Related]
15. TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.
Mohamed FEZA; Dewidar B; Lin T; Ebert MP; Dooley S; Meindl-Beinker NM; Hammad S
Int J Exp Pathol; 2024 Apr; 105(2):64-74. PubMed ID: 38328944
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
Han L; Huang C; Zhang S
Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
[TBL] [Abstract][Full Text] [Related]
17. Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells.
Vitale DL; Caon I; Parnigoni A; Sevic I; Spinelli FM; Icardi A; Passi A; Vigetti D; Alaniz L
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572239
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
19. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
20. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
